Improved survival after single-unit cord blood transplantation using fludarabine and melphalan-based reduced-intensity conditioning for malignant lymphoma: impact of melphalan dose and graft-versus-host disease prophylaxis with mycophenolate mofetil-Reference-Cited by-同舟云学术

Improved survival after single-unit cord blood transplantation using fludarabine and melphalan-based reduced-intensity conditioning for malignant lymphoma: impact of melphalan dose and graft-versus-host disease prophylaxis with mycophenolate mofetil

Published:2022-10-05 Issue:12 Volume:101 Page:2743-2757
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Sakatoku Kazuki,Kim Sung-Won^ORCID,Okamura Hiroshi,Kanaya Minoru,Kato Koji,Yamasaki Satoshi,Uchida Naoyuki,Kobayashi Hikaru,Fukuda Takahiro,Takayama Nobuyuki,Ishikawa Jun,Nakazawa Hideyuki,Sakurai Masatoshi,Ikeda Takashi,Kondo Tadakazu,Yoshioka Satoshi,Miyamoto Toshihiro,Kimura Takafumi,Ichinohe Tatsuo,Atsuta Yoshiko,Kondo Eisei

Funder

National Cancer Research and Development Fund

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-022-04990-w.pdf

Reference42 articles.

1. Ballen KK, Gluckman E, Broxmeyer HE (2013) Umbilical cord blood transplantation: the first 25 years and beyond. Blood 122:491–498

2. Mayani H, Wagner JE, Broxmeyer HE (2020) Cord blood research, banking, and transplantation: achievements, challenges, and perspectives. Bone Marrow Transplant 55:48–61

3. Corradini P, Dodero A, Farina L, Fanin R, Patriarca F, Miceli R et al (2007) Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome. Leukemia 21:2316–2323

4. Burroughs LM, O’Donnell PV, Sandmaier BM, Storer BE, Luznik L, Symons HJ et al (2008) Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma. Biol Blood Marrow Transplant 14:1279–1287

5. Chen R, Palmer JM, Popplewell L, Shen J, Smith E, Delioukina M et al (2011) Reduced intensity allogeneic hematopoietic cell transplantation can induce durable remission in heavily pretreated relapsed Hodgkin lymphoma. Ann Hematol 90:803–808

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Center effect on allogeneic hematopoietic stem cell transplantation outcomes for B-cell acute lymphoblastic leukemia;Cytotherapy;2024-05

2. Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study;Bone Marrow Transplantation;2024-02-08